However, for patients undergoing frequent UDS testing, selecting an agent least likely to cause false-positives would be an important consideration to help minimize adverse consequences to patients from potentially misinterpreted results
In this regard, there has been a tremendous interest in the study of zinc and selenium in this disease
Emerging research suggests that addressing inflammation, promoting cellular repair, and balancing hormone production could provide a more comprehensive approach to managing depression
After screening according to the criteria for positive signals, we identified different psychiatric AEs related to different GPL-1 RA therapies
Visible weight loss typically becomes apparent after 2-3 months as you reach higher doses
Educational information about Retatrutide clinical development and ongoing research